MGNX
Price
$1.46
Change
+$0.08 (+5.80%)
Updated
Jul 3 closing price
Capitalization
92.11M
37 days until earnings call
TCRX
Price
$1.51
Change
+$0.04 (+2.72%)
Updated
Jul 3 closing price
Capitalization
85.45M
38 days until earnings call
Interact to see
Advertisement

MGNX vs TCRX

Header iconMGNX vs TCRX Comparison
Open Charts MGNX vs TCRXBanner chart's image
MacroGenics
Price$1.46
Change+$0.08 (+5.80%)
Volume$699.98K
Capitalization92.11M
TScan Therapeutics
Price$1.51
Change+$0.04 (+2.72%)
Volume$185.96K
Capitalization85.45M
MGNX vs TCRX Comparison Chart in %
Loading...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGNX vs. TCRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (MGNX: $1.46 vs. TCRX: $1.51)
Brand notoriety: MGNX and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 51% vs. TCRX: 28%
Market capitalization -- MGNX: $92.11M vs. TCRX: $85.45M
MGNX [@Biotechnology] is valued at $92.11M. TCRX’s [@Biotechnology] market capitalization is $85.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • MGNX’s TA Score: 5 bullish, 5 bearish.
  • TCRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both MGNX and TCRX are a good buy in the short-term.

Price Growth

MGNX (@Biotechnology) experienced а +14.96% price change this week, while TCRX (@Biotechnology) price change was +2.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MGNX is expected to report earnings on Nov 11, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($92.1M) has a higher market cap than TCRX($85.5M). TCRX YTD gains are higher at: -50.329 vs. MGNX (-55.077). MGNX has higher annual earnings (EBITDA): -47.33M vs. TCRX (-124.58M). TCRX has more cash in the bank: 252M vs. MGNX (154M). MGNX has less debt than TCRX: MGNX (37.5M) vs TCRX (97M). MGNX has higher revenues than TCRX: MGNX (152M) vs TCRX (4.42M).
MGNXTCRXMGNX / TCRX
Capitalization92.1M85.5M108%
EBITDA-47.33M-124.58M38%
Gain YTD-55.077-50.329109%
P/E RatioN/AN/A-
Revenue152M4.42M3,438%
Total Cash154M252M61%
Total Debt37.5M97M39%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MGNXTCRX
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSLOY16.800.05
+0.30%
Mitsui O.S.K. Lines Ltd.
HRIBF61.03N/A
N/A
Horiba Ltd.
AFSIB15.00N/A
N/A
AmTrust Financial Services, Inc.
ORYZF3.22N/A
N/A
Oryzon Genomics SA
ECRFF0.08-0.01
-8.99%
Cartier Resources, Inc.

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+5.80%
CRBU - MGNX
51%
Loosely correlated
N/A
XNCR - MGNX
50%
Loosely correlated
+1.45%
BEAM - MGNX
47%
Loosely correlated
+0.65%
SYRE - MGNX
46%
Loosely correlated
+1.68%
RGNX - MGNX
46%
Loosely correlated
+1.39%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+2.72%
FATE - TCRX
46%
Loosely correlated
N/A
CRBU - TCRX
44%
Loosely correlated
N/A
MGNX - TCRX
43%
Loosely correlated
+5.80%
IMNM - TCRX
43%
Loosely correlated
+2.43%
PRME - TCRX
41%
Loosely correlated
+1.30%
More